MAO-A/5-HT2AR-IN-1

MAO-A/5-HT2AR-IN-1(compound I14)是一种有效的 MAO-A 和 5-HT2AR 双重抑制剂,对二者的 IC50 分别为 0.004 和 0.014 μM,是一种潜在的抗抑郁剂。
产品编号: MS-J43406 纯度: 99.71% CAS No.: 2769156-00-3 分子式: C30H28FN3O2 分子量: 481.56
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
询价
50mg
询价
询价
100mg
询价
询价

产品描述

MAO-A/5-HT2AR-IN-1(compound I14)是一种有效的 MAO-A 和 5-HT2AR 双重抑制剂,对二者的 IC50 分别为 0.004 和 0.014 μM,是一种潜在的抗抑郁剂。

生物实验数据

生物活性 MAO-A/5-HT2AR-IN-1 (compound I14) is a potent dual inhibitor of MAO-A and 5-HT2AR with IC50 values of 0.004 and 0.014 μM, respectively, and is a potential antidepressant.
IC50 & Target

MAO-A

0.004 ± 0. μM (IC50)

5-HT2A Receptor

0.014 μM (IC50)

MAO-B

1.05 ± 0.0 μM (IC50)

体外研究
(In Vitro)

MAO-A/5-HT2AR-IN-1 (compound I14) (0-4 μM, 24 h) exhibits a significant neurocytoprotective effect on the CORT-induced cell depression model.
MAO-A/5-HT2AR-IN-1 is able to occupy the active cavity of 5-HT2AR and MAO-A with multiple hydrogen bonding forces and π–π stacking interaction.
MAO-A/5-HT2AR-IN-1 exhibits low proliferation inhibitory activities against L02 cells (IC50 > 100 μM), SH-SY5Y (IC50 > 10 μM) and PC12 (IC50 > 10 μM), indicating it has a good safety profile.

Cell Line: PC12 cells
Concentration: 4.0, 2.0, 1.0, and 0.5 μM (and 500 μM CORT)
Incubation Time: 24 h
Result: Showed a significant protective effect on PC12 cells injury at different concentrations compared with the model group, where the best protective effect was observed at 0.5 μM.
体内研究
(In Vivo)

MAO-A/5-HT2AR-IN-1 (compound I14) (10 and 20 mg/kg) significantly ameliorates the depression-like behavior of mice.
MAO-A/5-HT2AR-IN-1 (0-1 μM, for 7 days) improves zebrafish locomotion and the depression-like behavior.
MAO-A/5-HT2AR-IN-1 is able to repair the damage of mice hippocampal neuronal cells and reduce the expression of 5-HT2AR in mice brain tissue.
MAO-A/5-HT2AR-IN-1 (2 mg/kg (i.v.) 10 mg/kg (i.g.); once) has a good clearance rate of 345.69 mL/min/kg in rats.

Animal Model: ICR male mice (8−10 weeks old, weight 18-20 g)
Dosage: 10 mg/kg, 20 mg/kg
Administration: For 2 weeks
Result: Significantly improved depression-like behavior in mice, with the low dose group (10 mg/kg) being more potent than with the positive drug (Flu, 20 mg/kg). Had no relevant toxic effects on the liver, kidney, lung, and spleen of mice during the treatment period.
Animal Model: Zebrafish (AB strain, Reserpine-induced zebrafish depression model)
Dosage: 0.1, 0.5, 1 μM
Administration: Given 24 h after reserpine, for 7 days.
Result: Showed that zebrafish in the I14 administered group moved significantly more distance, faster, and spent significantly more time in the upper part compared to the model group.
Animal Model: Sprague-Dawley rats (male)
Dosage: 2 mg/kg (i.v.) 10 mg/kg (i.g.)
Administration: IV, IG; once (Pharmacokinetic Analysis)
Result: Pharmacokinetic Parameters of MAO-A/5-HT2AR-IN-1 in male Sprague-Dawley rats.
parameter 2 mg/kg (i.v.) 10 mg/kg (i.g.)
Tmax (h) 0.08 ± 0.00 1.33 ± 0.33
Cmax (ng/mL) 673.33 ± 25.41 99.67 ± 6.01
AUC0-24 (ng/mL·h) 2230.67 ± 153.78 490.67 ± 70.43
AUC0-inf (ng/mL·h) 2322.67 ± 178.02 504.00 ± 71.08
t1/2 (h) 6.31 ± 0.55 5.22 ± 0.79
CL (mL/min/kg) 14.54 ± 1.20 345.69 ± 53.40
MRTinf (h) 4.19 ± 0.14 4.94 ± 0.36
F (%) 4.40
性状 固体
颜色 Light yellow to yellow

化学信息

分子量 481.56
分子式 C30H28FN3O2
CAS No. 2769156-00-3

储存&溶解度

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMF 中的溶解度 : 1 mg/mL (2.08 mM; 超声助溶 (<60°C))

可选溶剂浓度1 mg5 mg10 mg25 mg
DMF1 mM2.0766 mL10.3829 mL20.7658 mL51.9146 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础